WBAL-TV on MSN4d
Woman's Doctor: Women of child-bearing age need to be vigilant for ulcerative colitis symptoms
The causes of ulcerative colitis aren't quite known, but women of child-bearing age should be especially vigilant for ...
Medical Xpress11d
Clinical guideline for moderate-to-severe ulcerative colitis released
The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...
Medscape9d
Health Maintenance in Ulcerative Colitis: 5 Things to Know
Addressing all aspects of healthcare maintenance in ulcerative colitis (UC) — one of two major types of inflammatory bowel ...
Daily4d
First American Gastroenterological Association living guideline for moderate-to-severe ulcerative colitis
The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...
Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...
FiercePharma12d
Cleanup for the IL-23 class in ulcerative colitis as new drugs 'rapidly gained significant momentum': report
The new ulcerative colitis (UC) triumvirate in Johnson & Johnson’s Tremfya, AbbVie’s Skyrizi and Eli Lilly’s Omvoh is rapidly ...
Daily1d
JnJ seeks USFDA approval for subcutaneous induction regimen of Tremfya in ulcerative colitis
Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and ...
GlobalData on MSN7d
J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
The request is based on findings from the Phase III ASTRO study, which achieved the primary endpoint of clinical remission at ...
Armed robbery in Revesby11d
AGA Releases Guideline for Severe Ulcerative Colitis
The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...
Palatin Completes Patient Enrollment In Phase 2 Study Of PL8177 In Ulcerative Colitis, Shares Up 16%
Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...